Sentences with phrase «risk than growth»

They tend to be lower risk than growth investments, but have their place in any retirement plan.

Not exact matches

The result is Canada is at «some risk» of a balance sheet recession — a period of slow growth or decline caused by consumers saving and paying down debt rather than spending.

Asia and Latin America are not risk - free, but «there seems to be sense in buying equities in these regions on similar or lower valuations than their counterparts in the developed world given that dividend growth is likely to be superior, given higher economic growth potential.»

Powell in statements throughout the year, culminating with his recent Senate confirmation hearing, has been clear he sees little risk of inflation that would prompt the Fed to raise rates faster than expected, and takes weak wage growth as a sign that sidelined workers remain to be drawn into jobs.

TriLinc looks for established social enterprises in stable emerging markets that are ripe for growth capital and represent a lower risk than early - stage companies.

We believe the Statoil acquisition strengthens the company's business risk profile by adding an established, profitable c - store and fuel retailer with a strong market share of more than 30 % in the mature markets of Sweden, Norway, and Denmark with good growth prospects in riskier, more fragmented Eastern Europe.

If the Bank of Canada were to tolerate growth faster than that for too long, it would risk exceeding its inflation target.

Such capital - intensive growth is not without considerable risks, but investing in more than you need — C.R. Plastic's latest home is three times the size of its previous headquarters — can be smart, «[if] you've got good market indicators that you will grow into it,» according to Susan Rohac, vice-president of growth and transition capital for Ontario and Atlantic Canada at BDC.

Global growth has slowed more than investors had previously anticipated and political risk has risen; yet over the past four years flows into emerging markets funds have remained very strong despite their underperformance.

That is, Uber's propensity for risk has caused it to target a rate of growth much faster than what would be sustainable if it were to seek profitability in the short run (and, arguably, in the long run), and has also led both to oversights and deliberate missteps in areas that have led to the controversies that plague it today.

«There was still a risk that growth in consumption might turn out to be weaker than forecast if household income growth were to increase by less than expected.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

If policy developments in advanced economies make the path for growth and debt less benign than expected, risk premiums and volatility could rise sharply.

Such caution is especially warranted given the asymmetric risk scenario recently outlined by Fed governor Lael Brainard (the risks of weaker demand are greater than those of accelerating price growth).

One area of uncertainty relates to wages growth, where there is a risk that current labour market tightness will result in higher - than - expected wage increases.

World growth will remain low on average but negative in the UK and Europe; price inflation will remain sufficiently subdued for a while longer so as to impose no constraint on monetary expansion; central banks will sustain a regime of negative real interest rates and rapid monetary expansion; the risk of a eurozone collapse is off the table for now; finally, stock markets should continue to perform better than expected, even though the four - year old cyclical bull market is long by historical standards.

Comparing our opportunity to Japan's, isn't our sovereign credit risk much higher than Japan's in terms of per capita GDP growth, structural balance - of - payments deficit, history of default and history of inflation?

Investing in a digital currency is extremely high - risk — more so than traditional startup investing — but is motivated largely by the explosive growth in the value of bitcoins, each of which is now worth around $ 4,000 at the time of publication.

The Triffin Dilemma, as this problem is known, points out that if foreign growth is high enough relative to US growth that the need for US dollar reserves grows faster than the US economy, the resulting US current account deficit will require that the US sell assets fast enough, or that US obligations to foreigners grow fast enough, eventually to put the US economy at risk.

Strategic Growth is a risk - managed growth fund that is intended to accept exposure to U.S. stocks over the full market cycle, but with smaller periodic losses than a passive buy - and - hold appGrowth is a risk - managed growth fund that is intended to accept exposure to U.S. stocks over the full market cycle, but with smaller periodic losses than a passive buy - and - hold appgrowth fund that is intended to accept exposure to U.S. stocks over the full market cycle, but with smaller periodic losses than a passive buy - and - hold approach.

The PBO identified four key downside risks to the private sector forecast: global growth, especially in the U.S. could be slower than anticipated; the appreciation of the Canadian dollar could adversely affect exports; sovereign debt issues in Europe could restrain recovery there and put upward pressure on global interest rates; and the high level of household debt in Canada could restrain domestic demand.

And for all the muddle, the one thing that seems clear is that the risks to the economy and particularly the labor market — which is generating solid job growth and even some wage gains (for which we should all give Chair Yellen and the Fed serious credit)-- remain «asymmetric:» there's a greater risk of needlessly slowing non-inflationary growth than there is of inflation accelerating.

Factors that could cause actual results to differ materially from those expressed or implied in any forward - looking statements include, but are not limited to: changes in consumer discretionary spending; our eCommerce platform not producing the anticipated benefits within the expected time - frame or at all; the streamlining of the Company's vendor base and execution of the Company's new merchandising strategy not producing the anticipated benefits within the expected time - frame or at all; the amount that we invest in strategic transactions and the timing and success of those investments; the integration of strategic acquisitions being more difficult, time - consuming, or costly than expected; inventory turn; changes in the competitive market and competition amongst retailers; changes in consumer demand or shopping patterns and our ability to identify new trends and have the right trending products in our stores and on our website; changes in existing tax, labor and other laws and regulations, including those changing tax rates and imposing new taxes and surcharges; limitations on the availability of attractive retail store sites; omni - channel growth; unauthorized disclosure of sensitive or confidential customer information; risks relating to our private brand offerings and new retail concepts; disruptions with our eCommerce platform, including issues caused by high volumes of users or transactions, or our information systems; factors affecting our vendors, including supply chain and currency risks; talent needs and the loss of Edward W. Stack, our Chairman and Chief Executive Officer; developments with sports leagues, professional athletes or sports superstars; weather - related disruptions and seasonality of our business; and risks associated with being a controlled company.

Logically, by taking more risk — in paying up to own «growth» stocks at higher multiples than the market average — one should expect to achieve higher returns.

My students at Peking University, for example, are extremely supportive and think very differently about what I do, and I think I have convinced them that as future policymakers, especially in finance and central banking, rather than join the hype that has always accompanied every growth miracle it is their responsibility to be focus on risks and on all the ways things can go wrong.

These risks and uncertainties include food safety and food - borne illness concerns; litigation; unfavorable publicity; federal, state and local regulation of our business including health care reform, labor and insurance costs; technology failures; failure to execute a business continuity plan following a disaster; health concerns including virus outbreaks; the intensely competitive nature of the restaurant industry; factors impacting our ability to drive sales growth; the impact of indebtedness we incurred in the RARE acquisition; our plans to expand our newer brands like Bahama Breeze and Seasons 52; our ability to successfully integrate Eddie V's restaurant operations; a lack of suitable new restaurant locations; higher - than - anticipated costs to open, close or remodel restaurants; increased advertising and marketing costs; a failure to develop and recruit effective leaders; the price and availability of key food products and utilities; shortages or interruptions in the delivery of food and other products; volatility in the market value of derivatives; general macroeconomic factors, including unemployment and interest rates; disruptions in the financial markets; risk of doing business with franchisees and vendors in foreign markets; failure to protect our service marks or other intellectual property; a possible impairment in the carrying value of our goodwill or other intangible assets; a failure of our internal controls over financial reporting or changes in accounting standards; and other factors and uncertainties discussed from time to time in reports filed by Darden with the Securities and Exchange Commission.

Growth outlook in the eurozone remains broadly balanced with chances of better than expected economic growth, while downside risks are largely associated with global factors, including the forex (foreign exchange) maGrowth outlook in the eurozone remains broadly balanced with chances of better than expected economic growth, while downside risks are largely associated with global factors, including the forex (foreign exchange) magrowth, while downside risks are largely associated with global factors, including the forex (foreign exchange) markets.

This could include setting targets for nominal GDP growth rather than inflation, investing in a wider range of risk assets, making plans to allow base rates to turn negative, and underscoring the importance of avoiding a new recession.

Stronger - than - expected earnings growth of 18 % for the S&P 500 have helped stocks move higher, but potential causes of volatility, including additional tariff proposals and rising interest rates, continue to be headline risks.

We see future returns driven primarily by income in fixed income and earnings growth in equities, rather than by a re-rating spurred by a decline in rates and risk.

While the risks to the global outlook seem more balanced than they have been for some time, the prospects for a pick - up in global growth remain subject to significant uncertainty.

The move was widely seen as a further sign of the shifting priorities of the Chinese government, with more of a focus on stability and risk management, rather than on the creation of additional debt in order to sustain previous levels of growth.

China's economic growth target for 2017 was announced by the country's leadership as around 6.5 %, a move widely seen as a further focus on stability and risk management, rather than on the creation of additional debt in order to sustain previous levels of growth.

Because these venture capital firms want higher return rates than other investments such as the stock market provide, they typically invest in promising startup or young businesses that have a high potential for growth but are also high risk.

Since the start of this decade the rate of growth of what was perceived to be low risk assets at many banks, was significantly higher than the rate of growth of capital, a trend that played a great part in the collapse of many financial institutions.

With the risks to the Australian economy from abroad abating further over recent months, and with signs that domestic growth was running faster than expected, the Board's deliberations turned to the question of how much longer such an expansionary stance of policy should be maintained.

There are, of course, risks to those expectations — specifically a US growth slowdown — but there seems little doubt that if you are looking for growth you are more likely to find it in Asia than anywhere else.

As the chart below shows, a hypothetical balanced index portfolio that hasn't been rebalanced to policy weights since the bottom of the Great Financial Crisis on March 9, 2009 would look more like a growth portfolio today, exposing the investor to more risk than initially agreed upon.

Keep in mind that HASI's has maintained a more predictable dividend growth profile than the mREIT peers, so from a risk / return perspective, I consider HASI's platform more appealing.

«AbbVie's Baa1 rating reflects the blockbuster success of Humira and the product's good growth outlook, offset by higher leverage and greater product concentration risk than pharmaceutical peers,» says Michael Levesque, analyst at Moody's Investors Service.

«While the recent downtick in growth coupled with the uptick in various inflation indicators from wages to commodity prices, has been relatively modest, investors are now more open to the risk of stagflation than previously,» he said.

Rather than encouraging them to seek higher goals, it can thus inoculate them against taking the risks that may be necessary for true growth to emerge.

In fact, most (63 %) said it was «diverting the church from more important things,» and, in a list of church priorities, ranked sexuality issues lower than creating disciples of Christ, spiritual growth, youth involvement, members» spiritual growth, decline in membership, poverty, children at risk, and social injustice.

«Investing in more speed and capacity than is necessary not only increases costs today without a corresponding benefit but it also adds the risk that if and when projected growth is achieved, the once modern machinery may be worn to the point that repair or replacement is needed or worse, it may be made obsolete by new technology.

Supervised coaching for proper mechanics can correct these errors and does not pose any higher risk for growth plate injuries than any other sport or activity.

The estimated percentage of US children aged 2 to 5 years and 6 to 11 years classified as overweight increased from 5.0 % and 6.5 % in 1980 to 10.4 % and 19.6 %, respectively, in 2007 -2008.1-3 The increase in childhood obesity was also observed among those aged 6 to 23 months, from 7.2 % in 1980 to 11.6 % in 2000.1 Given the numerous health risks related to childhood obesity,4 - 7 its prevention is becoming a public health priority.8 It has been reported that feeding practices affect growth and body composition in the first year of life, with breastfed infants gaining less rapidly than formula - fed infants.9 - 14 There is also evidence that breastfed infants continue to have a low risk for later childhood obesity.15 - 18

When we compare the death rate at homebirth of 2.06 / 1000 with the CDC death rate for low risk white women, ages 20 - 44, at term, with babies that are not growth restricted of 0.38, we find that homebirth has a death rate 5.5 X higher than hospital birth.

«Additional sources of risk to the household sector include slower housing market growth than expected, brought about in part by strong home price growth, as well as a steeper slowdown in auto sales than anticipated.»

«But as we have consistently argued, by making a political choice to cut the deficit further and faster than any other major country George Osborne is going too deep and too fast and putting jobs and growth at risk.

Active surveillance involves regular testing to check for cancer growth rather than immediate treatment, and many patients with low - risk prostate cancer on active surveillance may be able to avoid treatment for several years or altogether.